$77.40
al cierre: Aug 24, 5:00 PM EST
BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG
BPMUFOTCPK
BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG Financials
BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (BPMUF) financial statements — income, revenue, gross margin and key metrics.